Influenza B viruses having alterations in the hemaglutinin polypeptide
US8673613B2 · kind B2 · utility
5Cited by
36References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2008 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Jul 8, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16261
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses methods of producing influenza B viruses in cell culture. The influenza B viruses may have desirable characteristics, such as enhanced replication in eggs and may be used, for example, in vaccines and in methods of treatment to protect against influenza B virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.